General Information:

Id: 1,089 (click here to show other Interactions for entry)
Diseases: Amyotrophic lateral sclerosis
Mus musculus
SOD-G93A mouse
Reference: Fornai F et al.(2008) Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 105: 2052-2057 [PMID: 18250315]

Interaction Information:

Comment In SOD-G93A mice, lithium treatment prolonged the mean survival time from 110.8 days to 148 and, most importantly, increased disease duration (from a mean of 9 days to 38 days) compared with the G93A mice treated with saline.
Formal Description
Interaction-ID: 6902

drug/chemical compound


decreases_activity of


Amyotrophic lateral sclerosis

Drugbank entries Show/Hide entries for Lithium